Project Grant R21EB037917
- Federal Grant Award Summary Massachusetts General Hospital (MGH), doing business as The General Hospital Corporation, received a $206,250 Project Grant from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286). The award, effective June 1, 2026 through May 31, 2029, supports the development and feasibility evaluation of an integrated mechano-arthroscope—a...
- Federal Grant Award Summary The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded Massachusetts General Hospital a $622,804 Project Grant on June 2, 2026, under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to develop quantitative point-of-care magnetic resonance imaging (MRI) technology for breast cancer screening. The project, which extends through March 31, 2030, addresses a critical healthcare need...
- Federal Project Grant Award Summary The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded the Trustees of Boston University a Project Grant of $613,124 under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) for the period August 15, 2025, through July 31, 2028. The project delivers the development and demonstration of Quantitative Phase Imaging Meta-Sensors (PIMSs)—advanced optical imaging sensors that...
- Federal Grant Award Summary The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded Massachusetts General Hospital $656,750 through the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) on August 1, 2025, for a three-year project period concluding July 31, 2028. The award funds research to develop and optimize Electrical Impedance Tomography (EIT) as a bedside imaging tool for assessing lung perfusion in acute...
- Federal Grant Award Summary Northeastern University received a $219,818 Project Grant from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), awarded on April 27, 2026, with completion targeted for January 31, 2029. The project focuses on developing a fully integrated electro-optic sensor designed to enable real-time magnetic resonance imaging (MRI) guided...
- Federal Project Grant Award Summary The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded Massachusetts General Hospital $269,460 under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) for the period August 1, 2025 through July 31, 2027. The award funds research and development of advanced magnetic resonance imaging (MRI) acquisition and analysis methods designed to enhance the detection and...
- Federal Grant Award Summary Award Details: The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded Boston Children's Hospital a Project Grant of $996,466 under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286). The award commenced August 1, 2025, with a completion date of May 31, 2029. Deliverables: This project will develop and validate an innovative motion- and distortion-robust quantitative MRI (QMRI) imaging...
- The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded a $1,295,800 Project Grant under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to develop a novel optical endoscope that does not require mechanical rotation to perform 360-degree in vivo imaging. The project aims to design and fabricate a metasurface that can...
- Federal Grant Award Summary Massachusetts General Hospital received a $165,000 Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) for a two-year project period beginning August 1, 2025 and concluding July 31, 2027. The award supports research focused on modeling and safety assessment of magnetic spinal cord stimulation (MSCS), an...
- Federal Grant Award Summary Massachusetts General Hospital received a $1,061,520 Project Grant from the National Institutes of Health (NIH) Office of the Director under the Research Infrastructure Programs (CFDA 93.351) to procure a VisuoSonics VEVO F2 LAZR-X20 photoacoustic and ultrasound imaging system. The award, made on May 1, 2026 with completion targeted for April 30, 2027, funds the acquisition and installation of this next-generation multi-modal imaging equipment at MGH's Boston facility...
Massachusetts General Hospital, through its Research Management Division, received a $247,500 Project Grant award dated June 6, 2026, from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286). The award funds development of a miniaturized, no-moving-parts scanning light endoscope designed to enable high-speed three-dimensional deep imaging into live biological systems. The project leverages advances in potassium tantalate niobite (KTN) crystal growth to create a compact electro-optic scanner capable of rapid optical focusing across volumetric tissue with microsecond response times, eliminating the mechanical limitations of traditional surface-examining endoscopy. Deliverables under this award, scheduled for completion by April 30, 2029, include physical modeling and simulation of complex interactions within KTN crystals, prototype endoscope design and manufacturing, preclinical device preparation, and performance validation through ex-vivo organ and living animal studies. These research and development activities directly support NIBIB's mission to advance biomedical imaging technologies and represent the type of device-driven innovation that characterizes the program's focus on discovering and validating new tools for disease prevention, detection, diagnosis, and treatment.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $247.5k | 6/9/26 |